Maisonneuve-Rosemont Hospital Université de Montréal


Partnerships help hasten discoveries


Through their capacity to optimize the organization of human, financial and technological resources, partnerships are crucial to the advancement of research. Indeed, they help hasten new discoveries.

The partnerships set up by the MRH’s Hematopoietic Stem Cell Transplantation Program team foster the sharing of expertise and the latest knowledge in ultraspecialized areas, as well as the pooling of state-of-the-art technological resources and infrastructure. Moreover, the financial resources made available to the Program’s research teams by generous partners and donors are certainly not to be overlooked, since it is mainly thanks to them that our doctors and researchers are able to accomplish small miracles each and every day.

In the end, it is patients—and society as a whole—who benefit from the strong partnerships that we have established over the last few years. Each of them, in their own way, has contributed to the growth of our transplantation program.

Our major partners
(in alphabetical order)

Québec Leukemia Cell Bank (QLCB)

The QLCB has set up a bank of leukemia and other blood cancer cells in order to provide hematological and oncological researchers with specimens of human blood tumours for investigative purposes. It also provides a chromosomal analysis diagnostic service for such tumours through conventional cytogenetic techniques and spectral karyotyping (SKY). The QLCB has contributed to the standardization of acute leukemia diagnostics and is the benchmark laboratory for all of Québec’s and Canada’s hematologists and oncologists. Its offices are located in MRH.

QLCB website

Centre of Excellence for Cellular Therapy

A component of MRH, the CECT will be inaugurated in 2010. Involving a number of technological platforms, it will provide researchers and clinicians with advanced laboratory services that will enable them to develop and improve various stem cell therapies.

CECT website

MRH Foundation

A cornerstone for development, the Foundation provides support for MRH projects to improve care, develop teaching initiatives and expand research. The foundation has granted $1 million over the last few years to consolidate the hematological oncology sector.

Foundation website | Make a donation to the Foundation

MRH Research Centre

The MRHRC is one of North America’s most dynamic hematological-oncological research centres. It brings together high-calibre researchers who work to enhance the store of knowledge in the area and develop innovative cellular therapies.

MRHRC website

Université de Montréal

The Université de Montréal is a major partner in that MRH is one of its affiliated hospitals. As such, UdeM provides MRH with human, financial and physical resources that enable it to train students within a hospital setting.

UdM website

Université de Montréal Institute for Research in Immunology and Cancer (IRIC)

IRIC’s main mission is to shed light on the workings of the immune system and its impact on the development of cancers in order to develop therapies to eliminate the suffering and premature deaths caused by them. In order to accomplish this, IRIC relies on 22 research units and 10 scientific platforms.

IRIC website

William Brock Fund

Lawyer William Brock, a patient who was diagnosed with leukemia in 2004 and treated successfully at MRH, created the William Brock Fund to support research and medical education on blood cancers.

Make a donation to the Fund | Watch William Brock tell his story (in French only) | Find out about William Brock ’s story (in French only)